CLINICAL SEQUELAE OF HYPERINSULINEMIA IN DIABETES-MELLITUS

被引:0
作者
STANDL, E
机构
[1] INST DIABET FORSCH MUNCHEN, MUNICH, GERMANY
[2] STADT KRANKENHAUS, MED ABT 3, W-8000 MUNICH 40, GERMANY
来源
KLINISCHE WOCHENSCHRIFT | 1992年 / 69卷
关键词
HYPERINSULINEMIA; INSULIN RESISTANCE; MACROVASCULAR DISEASE; INSULIN TREATMENT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Surprisingly enough, insulin has recently been suspected of promoting cardiovascular complications, provided it becomes effective in excess concentrations at the vascular walls. This applies to both endogenous hyperinsulinemia and insulin substitution performed exogenously with high insulin doses. Several large population studies in non-diabetics - carried out in Helsinki, Busselton and Paris - have proved recently that serum insulin concentration is an independent risk predictor for the occurrence of coronary heart disease. According to in vitro trials, insulin stimulates the proliferation of the smooth muscle cells in vascular media and the lipid synthesis, as well as lipid incorporation into the vascular wall. Very recent large-scale population studies in randomly selected type II diabetics (the Schwabing Study and one performed at Oxford) have revealed a close association between an endogenous insulin requirement, on the one hand, and the risk of macroangiopathy or coronary heart disease on the other.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 40 条
[21]   INSULIN AND HYPERTENSION - LESSONS FROM OBESITY [J].
LANDSBERG, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (06) :378-379
[22]   EVIDENCE FOR AN ASSOCIATION OF HIGH BLOOD-PRESSURE AND HYPERINSULINEMIA IN OBESE MAN [J].
MANICARDI, V ;
CAMELLINI, L ;
BELLODI, G ;
COSCELLI, C ;
FERRANNINI, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (06) :1302-1304
[23]  
MODAN M, 1987, DIABETES METAB, V13, P375
[24]  
OLGEMOLLER B, 1986, AKTUELLE ENDOKINOL S, V7, P96
[25]   MORTALITY AND SURVIVAL IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
PANZRAM, G .
DIABETOLOGIA, 1987, 30 (03) :123-131
[26]  
PFEIFLE B, 1987, DIABETES METAB, V13, P326
[27]  
PYORALA K, 1985, ACTA MED SCAND, P38
[28]  
PYORALA K, 1987, DIABETES METAB, V13, P345
[29]  
Pyorala K, 1979, Diabetes Care, V2, P131, DOI 10.2337/diacare.2.2.131
[30]  
REAVEN GM, 1987, LANCET, V2, P435